International Survey Reveals Opportunities to Improve Tuberculous Meningitis Management and the Need for Standardized Guidelines
Open Access
- 23 September 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 7 (11), ofaa445
- https://doi.org/10.1093/ofid/ofaa445
Abstract
Tuberculous meningitis (TBM) is a medical emergency, yet there are no standardized treatment guidelines for the medical or neurosurgical management of these patients and little data on neurocritical care. We conducted an international survey to understand current medical and neurosurgical TBM management and resource availability to provide baseline data needed for future multicenter trials addressing unanswered clinical research questions and the establishment of standardized guidelines. An online survey of 77 questions covering medical and neurosurgical TBM management aimed at clinicians/nurses treating TBM was distributed as an anonymous link through email invitation, international organizations’ membership distribution, and direct links on organizational webpages or social media. The survey remained open for 5 months. Data were summarized with frequencies and percentages. The survey had 222 responses from 43 countries representing 6 continents. Most respondents were from tertiary care facilities, with broad access to medical and neurosurgical resources. There was significant heterogeneity in general supportive care, and TBM-specific management demonstrated considerable divergence from current standard-of-care practices. The lack of standardized guidelines was identified as a major challenge in TBM management. General and neurocritical care were largely absent. Resources for bedside supportive care and noninvasive monitoring were broadly accessible. These findings suggest that current TBM management could be improved by the establishment of internationally accepted treatment guidelines based on available evidence, and that numerous centers have resources available to participate in future multicenter trials, even for basic interventions, that may further improve patient outcomes globally.Funding Information
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (K08-AI139371)
This publication has 35 references indexed in Scilit:
- Short Intensified Treatment in Children with Drug-susceptible Tuberculous MeningitisThe Pediatric Infectious Disease Journal, 2014
- Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trialAIDS, 2013
- Dexamethasone and Long-Term Outcome of Tuberculous Meningitis in Vietnamese Adults and AdolescentsPLOS ONE, 2011
- The Role of Aspirin in Childhood Tuberculous MeningitisJournal of Child Neurology, 2011
- Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)-Associated Tuberculous MeningitisClinical Infectious Diseases, 2011
- The neurosurgical and acute care management of tuberculous meningitis: Evidence and current practiceTuberculosis, 2010
- Three Approaches to Qualitative Content AnalysisQualitative Health Research, 2005
- Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and AdultsThe New England Journal of Medicine, 2004
- Outcome after traumatic brain injury improved by an organized secondary insult program and standardized neurointensive care*Critical Care Medicine, 2002
- Effect of Corticosteroids on Intracranial Pressure, Computed Tomographic Findings, and Clinical Outcome in Young Children With Tuberculous MeningitisPEDIATRICS, 1997